NASCSA News

Optional page description text area...

Header Content Region

Insert text, image or banner ads here, or just delete this text and leave this area blank!

portfolio1 portfolio2 portfolio3 portfolio4

Heading 1

This is an example of the content for a specific image in the Nivo slider. Provide a short description of the image here....

Heading 2

This is an example of the content for a specific image in the Nivo slider. Provide a short description of the image here....

Heading 3

This is an example of the content for a specific image in the Nivo slider. Provide a short description of the image here....

Heading 4

This is an example of the content for a specific image in the Nivo slider. Provide a short description of the image here....

get in touch



Wednesday - February 8, 2017 1:34 pm
View roundtable disscussion concerning heroin and synthetic drugs Continue reading →
Opioid Epidemic
Thursday - November 19, 2015 1:21 pm     A+ | a-
Opioid Epidemic - November 19, 2015

Link to this article:
http://www.jhsph.edu/research/centers-and-institutes/center-for-drug-safety-and-effectiveness/opioid-epidemic-town-hall-2015/2015-prescription-opioid-epidemic-report.pdf

November 2015

Johns Hopkins - Bloomberg School of Public Health
The Prescription Opioid Epidemic: An Evidence-Based Approach

More than 100,000 people in the United States have died directly or indirectly
from prescribed opioids since prescribing policies changed in the late 1990’s.
At that time, patient advocacy groups and pain specialists successfully lobbied
state medical boards and state legislatures to change statutes and regulations
to lift any prohibition of opioid use for non-cancer pain. In at least 20 states,
these new guidelines, statutes, regulations and laws dramatically liberalized the
long-term use of opioids for chronic non-cancer pain, reflecting the prevailing
thought at the time that there is no clinically appropriate ceiling on maximum
opioid dosing.8 An example of such permissive language can be found in Washington
State Administrative code (WAC) 246-919-830 from December 1999, which states:
“no disciplinary action will be taken against a practitioner based solely on the
quantity or frequency of opioids prescribed.”

With the introduction of pain as the “fifth vital sign”, accompanied by
pharmaceutical company efforts to market directly to prescribers there
has been a dramatic increase in prescription opioid sales. Studies have
documented a strong and consistent linear relationship between opioid
sales volume and morbidity and mortality associated with these products.

To read  complete article - Click link a top of this page

 


slide up button
NASCSA - Copyright 2012 - All Rights Reserved